TraceLink Reports Highest Quarterly Revenue and Record-Breaking Growth in EMEA New Sales Bookings for Q1 2017

Industry Reports
Typography

TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced financial and company results for the first quarter of 2017. 

Growth highlights for the first quarter of 2017 include:

  • A 126 percent year-over-year increase in Q1 new sales bookings, including unprecedented growth in the following regions:
  • A 658 percent increase in EMEA;
  • A 100 percent increase in India, and;
  • A 100 percent increase in APAC. 
  • A two-year revenue compound annual growth rate (CAGR) of 73 percent; and
  • A 71 percent increase in customer growth year-over year with 64 new customers added in Q1, for a total of 594 TraceLink customers.

“Our commitment to investing and expanding globally was truly evidenced this quarter by the record sales growth in all regions, including EMEA, India and APAC,” said Shabbir Dahod, president and CEO, TraceLink. "TraceLink’s continuous growth and remarkable performance is a result of our global talent, superior market leadership and our ability to meet the industry’s need for a proven, scalable solution that is seamless and cost-effective, while enabling timely compliance to meet serialization deadlines.”

Also in the first quarter, TraceLink announced NEXUS 17, taking place June 7 – 8 in Barcelona. As the industry’s premier venue for key industry leaders and stakeholders across the life sciences supply chain, NEXUS 17 will provide focused education and thought leadership from leading industry executives on the European Union Falsified Medicines Directive (EU FMD) and other global emerging track and trace regulations.

Additional growth highlights and milestones for the first quarter in 2017 include:

Continuing the expansion of the world’s largest track and trace network – hitting a milestone of 594 customers and over 250,000 trading partners on the TraceLink Life Sciences Cloud. TraceLink customers span the entire life sciences supply chain, including:

37 percent representing pharmaceutical and contract manufacturers;
7 percent representing wholesale distributors; and
56 percent representing pharmacies, hospitals and health systems, covering more than 4,200 U.S. dispensing locations.

Serving serialization customers across 24 countries – including the following:

  • 90 percent in the United States;
  • 8 percent in Europe, the Middle East and Africa (EMEA);
  • 2 percent in the rest of the world.

Expanding partnerships across services, specialties and industries – adding seven new partnerships in the first quarter to the TraceLink partner ecosystem, which now totals 30 partnerships with solution, integration and consulting providers across the U.S., EU, India and Asia-Pacific. Additionally, TraceLink covers over 90% of the U.S. hospital market through 13 agreements with group purchasing organizations (GPO), alliances, associations, management companies and cooperatives.

Demonstrating the industry’s only proven solution with the most live CMO connections on the network – with 162 CMOs live in production or in the process of going live, as of the end of Q1, and a 318% quarter over quarter increase in unique CMO connections on the network.

Executing unprecedented serial number volumes globally – commissioning more than 330 million serial numbers and processing 2.5 billion serialized events to date. 

Submitting compliance reports into the EU Hub nearly 18 months ahead of the EU FMD deadline – processing EU compliance reports for 415,000 units of product into the EU Hub with a proven and EMVO-tested solution.

Processing a total of 219 million Transaction History (TH) files for DSCSA lot-level compliance – a 146% increase from the total number of TH files processed by the end of Q1 2016.

Continuing rapid growth of the TraceLink Cloud Community, the industry’s largest forum on pharmaceutical track and trace - with 428 new members added in the first quarter, totaling more than 2,400 Cloud Community members that are able to interact with their peers from across the global supply chain.

About TraceLink
TraceLink is the World’s Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com

TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.

Media Contact
Aimee Genzler  
Director, Corporate Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
978.396.6150

 

Sign up via our free email subscription service to receive notifications when new information is available.
captcha 

Market Movers

Rogers Corporation

NYQ : ROG - 19 Sep, 2:30pm
127.8886
+0.3886 (+0.3048%) After Hours:
Open 128.0000 Mktcap 2.32B
High 128.0000 52wk Hight 128.0000
Low 127.0300 52wk Low 51.9800
Vol 26544 Avg Vol 120339
Eps 5.5500 P/e 30.8388
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 19 Sep, 2:31pm
6.795
+0.085 (+1.267%) After Hours:
Open 6.780 Mktcap 104.51B
High 6.800 52wk Hight 6.990
Low 6.760 52wk Low 4.190
Vol 3.66M Avg Vol 5.46M
Eps 0.490 P/e 12.560
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 19 Sep, 2:32pm
65.92
-0.07 (-0.11%) After Hours:
Open 66.02 Mktcap 179.79B
High 66.16 52wk Hight 66.80
Low 65.68 52wk Low 58.29
Vol 3.10M Avg Vol 8.07M
Eps 3.87 P/e 35.69
Currency: USD

Johnson & Johnson

NYQ : JNJ - 19 Sep, 2:32pm
135.30
-0.08 (-0.06%) After Hours:
Open 135.02 Mktcap 363.15B
High 135.79 52wk Hight 137.08
Low 134.35 52wk Low 109.32
Vol 2.59M Avg Vol 5.39M
Eps 7.18 P/e 22.89
Currency: USD

Pfizer, Inc.

NYQ : PFE - 19 Sep, 2:32pm
35.50
-0.05 (-0.14%) After Hours:
Open 35.66 Mktcap 211.13B
High 35.66 52wk Hight 35.84
Low 35.35 52wk Low 29.83
Vol 7.99M Avg Vol 17.45M
Eps 2.56 P/e 25.97
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 19 Sep, 12:59pm
13.71
+0.06 (+0.48%) After Hours:
Open 13.71 Mktcap
High 13.71 52wk Hight 16.29
Low 13.71 52wk Low 12.79
Vol 277 Avg Vol 4720
Eps P/e
Currency: USD